Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion

Summary

Objective of this study is to investigate of efficacy and safety of recombinant adenoviral human p53 Gene (rAd-p53) in treatment of malignant pleural effusion, compared to cisplatin. This is a phase 2, double blinded, randomized, active controlled study.

Timeline

Start

2015-06

Primary completion

2017-06

Completion

2017-06

Drugs

Indications